Bacterial meningitis

Bacterial meningitis is defined as an acute inflammatory process affecting the meninges—the protective membranes enveloping the central nervous system—secondary to bacterial invasion. The condition arises when pathogenic bacteria breach anatomical barriers such as the blood–brain barrier or enter via contiguous spread from adjacent infections (e.g., otitis media, sinusitis), or following trauma or neurosurgical intervention involving implanted devices. While the etiology varies by age and exposure context, the core pathological mechanism involves direct microbial proliferation within the subarachnoid space, triggering a robust host immune response that contributes significantly to neurological injury and systemic instability.

The classic clinical triad—neck stiffness, high fever, and altered mental status—is present in only ~44–46% of bacterial meningitis cases; its absence makes acute meningitis highly unlikely. In adults, severe headache occurs in nearly 90% of cases, followed by neck stiffness and photophobia/phonophobia. Young children often lack these hallmark signs and instead manifest nonspecific symptoms including irritability, drowsiness, poor feeding, or bulging fontanelle. A non-blanching rash may accompany certain bacterial etiologies, particularly Neisseria meningitidis infection. Early complications include sepsis, hypotension, and disseminated intravascular coagulation, which can precipitate multiorgan dysfunction and increase mortality risk if not rapidly addressed.

Bacterial meningitis is a globally distributed disease, with incidence and causative agents varying by age, geography, and healthcare access. In immunocompetent individuals, common pathogens include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b (Hib); however, the relative burden of each depends on local vaccination coverage and population demographics. In patients with compromised immunity or those with neurosurgical hardware, Gram-negative organisms such as Pseudomonas aeruginosa and Staphylococcus species predominate. Surveillance data indicate that while viral meningitis remains more prevalent overall, bacterial forms carry substantially higher case-fatality rates and are classified as medical emergencies requiring immediate intervention.

Direct transmission of bacterial meningitis does not typically occur person-to-person in the general population; rather, it results from endogenous seeding (e.g., hematogenous spread from respiratory or gastrointestinal reservoirs), contiguous extension from nearby infections, or iatrogenic inoculation during invasive procedures. Asymptomatic carriage of some pathogens (notably N. meningitidis and H. influenzae) in the nasopharynx facilitates colonization and potential dissemination under conditions of immune suppression or mucosal disruption. No evidence supports airborne or fecal-oral routes for primary meningitis acquisition in this context.

Individuals at highest risk include infants and young children due to immature immune responses; elderly persons with comorbidities; immunocompromised individuals (e.g., HIV-positive, post-transplant, or on immunosuppressive therapy); and those with structural CNS abnormalities or recent neurosurgical interventions. Travelers to endemic areas (e.g., the meningitis belt of sub-Saharan Africa) and military recruits living in close quarters also face elevated exposure risk. No additional risk group information is supported by the source snippets.

Vaccination against key bacterial causes—including meningococcal, pneumococcal, and Hib vaccines—has substantially reduced incidence in many regions. Post-exposure antibiotic prophylaxis (e.g., ciprofloxacin, rifampin, or ceftriaxone) is recommended for close contacts of confirmed cases of meningococcal disease to prevent secondary transmission. In healthcare settings, strict adherence to sterile technique during neurosurgical and device-related procedures minimizes risk of nosocomial meningitis. No universal chemoprophylaxis is indicated for the general public, and routine screening of asymptomatic carriers is not part of standard practice.

In sentinel surveillance systems, bacterial meningitis should be flagged when clinical presentation includes acute onset of fever, headache, and neck stiffness, especially if accompanied by altered consciousness or a non-blanching rash. Laboratory confirmation requires cerebrospinal fluid analysis showing elevated white cell count, low glucose, and positive culture or PCR for specific bacterial agents. Given the rapid progression and high mortality associated with this condition, timely reporting and linkage to epidemiological investigations are essential for outbreak detection and control. Source-backed detail on temporal trends, geographic clustering, or vaccine impact is not available from the provided snippets.

1. 1 Wikidata. bacterial meningitis.
2. 2 Wikipedia. Meningitis - Wikipedia.

ICD-10

ICD-11

Total cases

6K

Peak month

2017-09

Coverage

1 reporting countries · 2012-09-15 → 2026-05-02